“showed a trend”

Initial PCA analysis showed a trend for separation according to clinical status (stable or exacerbated).

Although the DN1 and CD8 + SP populations of Kmt2d +/βgeo showed a trend toward reduced leukocyte-specific integrin expression levels, the observed differences were not statistically significant ( Figure 2B ).

Interestingly, whilst sotagliflozin showed a trend towards the lowest risk of the composite of cardiovascular death or hospitalization for HF, dapagliflozin was associated with the lowest risk of all‐cause and cardiovascular mortality. 38 With SGLT2is forming the fourth cornerstone of HF treatment, vericiguat is awaiting additional trials in patients with stable HF to potentially become the fifth cornerstone 39 in the near future as it is currently indicated in patients after a worsening HF event only.

A comparison of these patient groups indicated that patients with symptoms of depression showed a trend towards a longer duration of epilepsy, which did not reach statistical significance.

Notably, and in line with other studies, AS + CA patients showed a trend towards higher age and male gender.

Even though probiotic group showed a trend toward lower incidence of VAP, the preventative effect was not statistically valid.

The results showed a trend of increased PLR in the active disease group compared with that in the inactive disease group, although the difference was not statistically significant.

GS-DHN was significantly increased in ob / ob mice (4.3-fold) and showed a trend toward increased levels in high fat–fed mice (14.8-fold) ( Fig. 1 B ).

In all culture conditions, CD137-deficient Tregs showed a trend of less suppressive than the wild-type control but they were not statistically different ( Fig. 4 ).

Pre-EAE LQ-treated male mice showed a trend toward development of EAE symptoms but were not significantly different from the normal group.

Although the clinicopathologic characteristics of each group were not statistically different, the pCR group showed a trend toward smaller size compared to the non-pCR (PR and SD) group.

But cysteamine-treated group showed a trend of decrease in I/M ratio in 2 weeks, but no difference in 4 weeks.

However, patient profiles based on irregular investigations showed a trend that polyclonality of the cellular anti-HIV response was associated with retroviral load, because strong and broad CD8 + lymphocyte responses against HIV pentamers were more frequently observed in patients with consistently detectable HIV-1 load.

The present study showed a trend consistent with prevalence estimates of mental health problems among adolescents in Vietnam and in Western countries.

The results also showed a trend towards lower ovulation rates in cycles with high AMH levels, but this did not reach statistical significance (Table 3 ).

However, AIDS patients showed a trend toward increase of Siglec-7 in their sera compared to healthy donors and, in particular, we found a direct and statistically significant correlation between HIV-RNA and serum levels of Siglec-7 in naïve HIV-1 infected patients, suggesting that a higher viral burden could induce the shedding of Siglec-7 in serum.

CXCL10 was decreased in those patients who died within 30 days, increased levels of IL-6 and IL-15 showed a trend towards higher odds of mortality at 30 days, and ferritin levels were higher in Gram-positive infections compared to Gram-negative infections.

High alcohol consumption showed a trend toward predicting therapy-associated mortality.

Both the A2620 and the Hyrax expanders showed a trend in the developed force that increased up to about 18–20 activations, after which a “plateau” was reached, while the Palatal Split Screw succeeded in increasing the force up to 24 activations (Figure 4 ).

RT-qPCR results showed that ZmUBP14 was significantly induced after low-temperature, high-temperature and drought stresses, and the expression level showed a trend of decreasing and then increasing after IAA and SA treatments (Fig. 10 b-d, f and g), suggesting that ZmUBP14 may respond to abiotic stresses by cross-linking multiple phytohormone signaling pathways.

Extending the results of a previous study that showed a trend toward a correlation of circulating irisin with BMI in subjects with a BMI range from 20 to 48 kg/m 2 ( 6 ), we previously reported a positive correlation of plasma irisin levels with BMI over a very broad spectrum of body weights with BMIs ranging from 8 to 85 kg/m 2 as well as positive associations with fat mass (FM), fat-free mass (FFM), and body cell mass (BCM) ( 11 ).

Among them, the TNT and IDEAL trials showed a trend toward an increase in new-onset diabetes for the atorvastatin 80 mg group compared with atorvastatin 10 mg (HR, 1.10; 95% CI, 0.94 to 1.29) or simvastatin 20 mg (HR, 1.19; 95% CI, 0.98 to 1.43).

In addition, average% PSA changes in the responder group showed a trend of PSA plateau.

Patients in more severe symptom groups showed a trend towards a higher number of comorbidities (Table 1 ) and were more likely to be on a current MM regimen (Table 2 ).

Ill participants as a group showed a trend of reduction of sweat volume on foot more than that of proximal sites by QSART compared to Controls, suggesting the possibility of a length-dependent small fiber dysfunction.